A technology that combines transcriptomic data and AI enables a novel approach to drug discovery based on the state of cells, ...

BostonGene, developer of the leading AI foundation model for cancer and the immune system, announced its participation at the 21st Annual Industry/Academia Precision Oncology & RadMed Symposium, where ...

Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...

The Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, has launched HTGAnalyzer, a new, easy-to-use, fast and reproducible bioinformatics tool for ...

Flowering Chinese cabbage, a staple leafy vegetable across Asia, has undergone decades of breeding to improve adaptability, ...

McMahon, Sean M. and Shue, Jessica. 2021. [Dataset] Dendrometer Data for Macrosystems Transcriptomic Research. Distributed by The Smithsonian Institution. https://doi ...

Phase II Study of Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and Fluorouracil in Locally Advanced Pancreatic Carcinoma: BTCRC-GI15-067 The prevalence and death rates of ...

Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.

Regorafenib response prediction in metastatic colorectal cancer by a novel genomic and transcriptomic model. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

A novel, validated seven-gene transcriptomic signature can predict TNF inhibitor response in patients with rheumatoid ...